Carta científico-clínica
Dermatosis Inmunoglobulina A lineal dishidrosiforme
Dyshidrosiform Linear Immunoglobulin A Dermatosis
Leído
8750
Vecesse ha leído el artículo
2703
Total PDF
6047
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 52 | 3 | 55 |
| 2025 5 | 110 | 29 | 139 |
| 2025 4 | 136 | 34 | 170 |
| 2025 3 | 130 | 20 | 150 |
| 2025 2 | 105 | 33 | 138 |
| 2025 1 | 81 | 27 | 108 |
| 2024 12 | 95 | 38 | 133 |
| 2024 11 | 99 | 63 | 162 |
| 2024 10 | 81 | 38 | 119 |
| 2024 9 | 75 | 22 | 97 |
| 2024 8 | 87 | 58 | 145 |
| 2024 7 | 119 | 35 | 154 |
| 2024 6 | 120 | 32 | 152 |
| 2024 5 | 94 | 48 | 142 |
| 2024 4 | 87 | 28 | 115 |
| 2024 3 | 60 | 29 | 89 |
| 2024 2 | 60 | 34 | 94 |
| 2024 1 | 52 | 23 | 75 |
| 2023 12 | 45 | 31 | 76 |
| 2023 11 | 60 | 30 | 90 |
| 2023 10 | 52 | 20 | 72 |
| 2023 9 | 56 | 22 | 78 |
| 2023 8 | 61 | 36 | 97 |
| 2023 7 | 84 | 32 | 116 |
| 2023 6 | 69 | 28 | 97 |
| 2023 5 | 81 | 36 | 117 |
| 2023 4 | 67 | 27 | 94 |
| 2023 3 | 59 | 23 | 82 |
| 2023 2 | 65 | 23 | 88 |
| 2022 1 | 56 | 24 | 80 |
| 2022 12 | 59 | 37 | 96 |
| 2022 11 | 78 | 46 | 124 |
| 2022 10 | 70 | 35 | 105 |
| 2022 9 | 62 | 58 | 120 |
| 2022 8 | 59 | 53 | 112 |
| 2022 7 | 53 | 50 | 103 |
| 2022 6 | 69 | 31 | 100 |
| 2022 5 | 103 | 45 | 148 |
| 2022 4 | 94 | 29 | 123 |
| 2022 3 | 54 | 52 | 106 |
| 2022 2 | 60 | 29 | 89 |
| 2021 1 | 68 | 41 | 109 |
| 2021 12 | 66 | 46 | 112 |
| 2021 11 | 43 | 51 | 94 |
| 2021 10 | 66 | 50 | 116 |
| 2021 9 | 54 | 37 | 91 |
| 2021 8 | 62 | 42 | 104 |
| 2021 7 | 38 | 30 | 68 |
| 2021 6 | 62 | 42 | 104 |
| 2021 5 | 70 | 42 | 112 |
| 2021 4 | 155 | 42 | 197 |
| 2021 3 | 77 | 34 | 111 |
| 2021 2 | 97 | 24 | 121 |
| 2020 1 | 65 | 30 | 95 |
| 2020 12 | 43 | 18 | 61 |
| 2020 11 | 30 | 6 | 36 |
| 2020 10 | 24 | 10 | 34 |
| 2020 9 | 35 | 14 | 49 |
| 2020 8 | 19 | 16 | 35 |
| 2020 7 | 42 | 16 | 58 |
| 2020 6 | 30 | 19 | 49 |
| 2020 5 | 28 | 26 | 54 |
| 2020 4 | 37 | 23 | 60 |
| 2020 3 | 27 | 24 | 51 |
| 2020 2 | 3 | 0 | 3 |
| 2020 1 | 4 | 1 | 5 |
| 2019 12 | 10 | 2 | 12 |
| 2019 11 | 5 | 1 | 6 |
| 2019 10 | 1 | 2 | 3 |
| 2019 9 | 6 | 7 | 13 |
| 2019 8 | 4 | 3 | 7 |
| 2019 7 | 4 | 5 | 9 |
| 2019 6 | 6 | 23 | 29 |
| 2019 5 | 6 | 18 | 24 |
| 2019 4 | 11 | 10 | 21 |
| 2019 3 | 5 | 8 | 13 |
| 2019 2 | 4 | 3 | 7 |
| 2019 1 | 2 | 4 | 6 |
| 2018 12 | 2 | 3 | 5 |
| 2018 11 | 1 | 3 | 4 |
| 2018 10 | 38 | 4 | 42 |
| 2018 9 | 8 | 0 | 8 |
| 2018 8 | 0 | 1 | 1 |
| 2018 7 | 1 | 7 | 8 |
| 2018 5 | 1 | 4 | 5 |
| 2018 4 | 0 | 7 | 7 |
| 2018 3 | 3 | 8 | 11 |
| 2018 2 | 45 | 9 | 54 |
| 2018 1 | 38 | 12 | 50 |
| 2017 12 | 58 | 7 | 65 |
| 2017 11 | 28 | 8 | 36 |
| 2017 10 | 57 | 19 | 76 |
| 2017 9 | 45 | 18 | 63 |
| 2017 8 | 47 | 12 | 59 |
| 2017 7 | 48 | 24 | 72 |
| 2017 6 | 38 | 23 | 61 |
| 2017 5 | 47 | 18 | 65 |
| 2017 4 | 30 | 19 | 49 |
| 2017 3 | 26 | 8 | 34 |
| 2017 2 | 55 | 24 | 79 |
| 2016 1 | 26 | 20 | 46 |
| 2016 12 | 49 | 20 | 69 |
| 2016 11 | 59 | 9 | 68 |
| 2016 10 | 68 | 29 | 97 |
| 2016 9 | 71 | 24 | 95 |
| 2016 8 | 48 | 15 | 63 |
| 2016 7 | 31 | 7 | 38 |
| 2016 6 | 9 | 11 | 20 |
| 2016 5 | 8 | 6 | 14 |
| 2016 4 | 7 | 6 | 13 |
| 2016 3 | 8 | 15 | 23 |
| 2016 2 | 4 | 9 | 13 |
| 2015 1 | 9 | 6 | 15 |
| 2015 12 | 5 | 7 | 12 |
| 2015 11 | 6 | 7 | 13 |
| 2015 10 | 4 | 4 | 8 |
| 2015 9 | 15 | 4 | 19 |
| 2015 8 | 5 | 2 | 7 |
| 2015 7 | 79 | 7 | 86 |
| 2015 6 | 54 | 6 | 60 |
| 2015 5 | 58 | 9 | 67 |
| 2015 4 | 42 | 13 | 55 |
| 2015 3 | 42 | 3 | 45 |
| 2015 2 | 34 | 3 | 37 |
| 2015 1 | 28 | 3 | 31 |
| 2014 12 | 25 | 4 | 29 |
| 2014 11 | 25 | 4 | 29 |
| 2014 10 | 36 | 8 | 44 |
| 2014 9 | 19 | 6 | 25 |
| 2014 8 | 25 | 5 | 30 |
| 2014 7 | 17 | 4 | 21 |
| 2014 6 | 29 | 15 | 44 |
| 2014 5 | 18 | 13 | 31 |
Mostrar todo
